PortfoliosLab logo

Better Therapeutics, Inc. (BTTX)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS08773T1043
CUSIP08773T104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.80
Year Range$0.91 - $17.14
EMA (50)$1.84
EMA (200)$4.80
Average Volume$8.37M
Market Capitalization$42.50M

BTTXShare Price Chart


Chart placeholderClick Calculate to get results

BTTXPerformance

The chart shows the growth of $10,000 invested in Better Therapeutics, Inc. on Mar 18, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,800 for a total return of roughly -82.00%. All prices are adjusted for splits and dividends.


BTTX (Better Therapeutics, Inc.)
Benchmark (^GSPC)

BTTXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-11.33%-6.21%
YTD-61.29%-18.17%
6M-64.84%-17.47%
1Y-81.87%-9.20%
5Y-75.30%-3.16%
10Y-75.30%-3.16%

BTTXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BTTXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Better Therapeutics, Inc. Sharpe ratio is -0.43. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BTTX (Better Therapeutics, Inc.)
Benchmark (^GSPC)

BTTXDividend History


Better Therapeutics, Inc. doesn't pay dividends

BTTXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BTTX (Better Therapeutics, Inc.)
Benchmark (^GSPC)

BTTXWorst Drawdowns

The table below shows the maximum drawdowns of the Better Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Better Therapeutics, Inc. is 94.68%, recorded on Apr 29, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.68%Nov 2, 2021124Apr 29, 2022
-15.22%Oct 28, 20212Oct 29, 20211Nov 1, 20213
-4.4%Oct 21, 20213Oct 25, 20212Oct 27, 20215
-3%Mar 18, 20211Mar 18, 2021135Oct 18, 2021136
-0.05%Oct 19, 20211Oct 19, 20211Oct 20, 20212

BTTXVolatility Chart

Current Better Therapeutics, Inc. volatility is 121.07%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BTTX (Better Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Better Therapeutics, Inc.


Loading data...